Literature DB >> 17029284

Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.

Yo-ichi Takei1, Takahisa Gono, Masahide Yazaki, Shu-ichi Ikeda, Toshihiko Ikegami, Yasuhiko Hashikura, Shin-ichi Miyagawa, Yoshinobu Hoshii.   

Abstract

Familial amyloid polyneuropathy (FAP) is a form of hereditary generalized amyloidosis. Liver tissue explanted from FAP patients has normal structure and function, except for the production of amyloidogenic variant transthyretin (TTR), and domino liver transplantation (DLT) using grafts from FAP patients was first performed in 1995. FAP symptoms usually develop in genetically determined individuals after the age of 20, but it is difficult to estimate when FAP symptoms will appear in domino recipients. Concerning this problem, histological findings showing amyloid deposition have recently been obtained in a few domino recipients of FAP livers. This study investigated the presence of de novo amyloid deposition in the gastroduodenal mucosa of domino recipients transplanted at our institution. Biopsy of gastroduodenal mucosa was carried out in 5 recipients of FAP livers and TTR-derived amyloid deposits were detected in 2 patients, both of whom had undergone DLT 47 months previously. In FAP liver recipients, de novo systemic amyloid deposition may begin much sooner than previously supposed. Therefore, careful follow-up of domino recipients of FAP livers is required. (c) 2006 AASLD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17029284     DOI: 10.1002/lt.20954

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

1.  Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?

Authors:  Joel N Buxbaum; Clement Tagoe; Gloria Gallo; John R Walker; Sunil Kurian; Daniel R Salomon
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

Review 2.  Endoplasmic reticulum quality control and systemic amyloid disease: Impacting protein stability from the inside out.

Authors:  John J Chen; Joseph C Genereux; R Luke Wiseman
Journal:  IUBMB Life       Date:  2015-05-26       Impact factor: 3.885

3.  Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.

Authors:  Gonçalo da Costa; Ricardo A Gomes; Ana Guerreiro; Élia Mateus; Estela Monteiro; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

4.  Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.

Authors:  Nina Norgren; Malin Olsson; Hanna Nyström; Bo Göran Ericzon; Marie de Tayrac; Emmanuelle Genin; Violaine Planté-Bordeneuve; Ole B Suhr
Journal:  Amyloid       Date:  2014-03-07       Impact factor: 7.141

5.  Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy.

Authors:  Velina Nedkova-Hristova; Carmen Baliellas; José González-Costello; Laura Lladó; Emma González-Vilatarsana; Valentina Vélez-Santamaría; Carlos Casasnovas
Journal:  Transpl Int       Date:  2022-04-13       Impact factor: 3.842

Review 6.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

7.  The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.

Authors:  Tsuneaki Yoshinaga; Masahide Yazaki; Yoshiki Sekijima; Fuyuki Kametani; Kana Miyashita; Naomi Hachiya; Tomohiro Tanaka; Norihiro Kokudo; Keiichi Higuchi; Shu-Ichi Ikeda
Journal:  J Pathol Clin Res       Date:  2016-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.